Otonomy Announces Multiple Presentations at Neuroscience 2021 Meeting

Back to Jobs

Presentation of positive top-line clinical results for OTO-313 in tinnitus and OTO-413 in hearing loss Supportive preclinical data to be presented for OTO-825 gene therapy and OTO-510 otoprotection program SAN DIEGO , Oct. 27, 2021 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a

Apply Now